Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes

Journal of Investigative Dermatology

Volumn 111, Issue 3, 1998, Pages 464-471

  Wagner, Stephan N ^a,d   Wagner, Christine ^a   Reinhold, Uwe ^b   Funk, Renate ^a   Zöller, Margot ^c   Goos, Manfred ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

CD4+ T cells; CD8+ T cells; Cutaneous lymphomas; Skin homing lymphocytes

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD44V ANTIGEN; CD8 ANTIGEN; CELL SURFACE RECEPTOR;

ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE HOMING; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; SEZARY SYNDROME; SKIN INFILTRATE; SKIN LYMPHOMA; T LYMPHOCYTE SUBPOPULATION;

EID: 0031717002     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00302.x     Document Type: Article

References (72)

1. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zöller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Sci (Wash DC) 257:682-685, 1992
2. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principle cell surface receptor for hyaluronate. Cell 61:1303-1313, 1990
3. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180:53-66, 1994
4. Bartolazzi A, Jackson D, Bennett K, et al: Regulation of growth and dissemination of a human lymphoma by CD44splice variants. J Cell Sci 108:1723-1733, 1995
5. Bennett KL, Jackson DG, Simon JC, et al: CD44 isoforms containing exon v3 are responsible for the presentation of heparin-growth factor. J Cell Biol 128:687-698, 1995a
6. Bennett KL, Modrell B, Greenfield B, et al: Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 131:1623-1633, 1995b
7. Bourguignon LYW, Lokeshwar VB, Chen X, Kerrick WGL: Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44) -cytoskeleton interaction. J Immunol 151:6634-6644, 1993
8. Butcher EC: Leukocyte-endothelial cell recognition: three (or more) steps to specifity and diversity. Cell 67:1033-1036, 1991
9. Chirgwin JM, Przybyla AE, McDonald RJ, Rutter WJ: Isolation of biologically active RNA from sources enriched in ribonuclease. Biochemistry 18:5294-5297, 1979
10. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229, 1984
11. DeGrendele HC, Estess P, Picker LJ, Siegelman MH: CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 183:1119-1130, 1996
12. Dommann SNW, Ziegler T, Dommann-Schener CC, Meyer J, Panizzon R, Burg G: CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas. J Cutan Pathol 22:407-412, 1995
13. Dougherty GJ, Dougherty ST, Eaves CJ, McBride WH: Expression of human CD44R1 enhances the metastatic capacity of murine fibrosarcoma cells. Proc Am Assoc Cancer Res 33:35-42, 1992
14. Dougherty GJ, Cooper DL, Memory JF, Chiu RK: Ligand binding specificity of alternatively spliced CD44 isoforms. J Biol Chem 269:9074-9078, 1994
15. Droll A, Dougherty ST, Chiu RK, Dirks JF, McBride WH, Cooper DL, Dougherty GJ: Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem 270:11567-11573, 1995
16. Ehnis T, Dieterich W, Bauer M, Lampe B, Schuppan D: A chondrotin/dermatan sulfate form of CD44 is a receptor for collagen XIV (undulin). Exp Cell Res 229:388-397, 1996
17. Faassen AE, Schrager JA, Klein DJ, Oegama TR, Couchman JR, McCarthy JB: A cell surface chondroitin sulfate proteoglycan, immunologically realted to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521-531, 1992
18. Fox SB, Gatter KC, Jackson DG, et al: CD44 and cancer screening. Lancet 342:548-549, 1993
19. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389:978-981, 1997
20. Ghaffari S, Dougherty GJ, Landsdorp PM, Eaves AC, Eaves CJ: Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 86:2976-2985, 1995
21. Goldstein LA, Zhou DFH, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC: A lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56:1036-1045, 1989
22. Günthert U: CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47-63, 1993
23. Günthert U, Hofmann M, Rudy W, et al: A new variant of glykoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24, 1991
24. Günthert U, Stauder R, Mayer B, Terpe H, Finke L, Friedrichs K: Are CD44 variant isoforms involved in human tumor progression? Cancer Surv 24:19-42, 1995
25. Harn HJ, Isola N, Cooper DL: The multispecific cell adhesion molecule CD44 is represented in reticulocyte cDNA. Biochem Biophys Res Commun 178:1127-1134, 1991
26. Haynes BF, Telen MJ, Hale LP, Denning SM: CD44-a molecule involved in leukocyte adherence and T cell activation. Immunol Today 10:423-428, 1989
27. Heider K-H, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, Pals ST: A human homologue of the rat metastasis-associated variant of CD44 is expressed i colorectal carcinomas and adenomatous polyps. J Cell Biol 120:227-223, 1993
28. Horst E, Meijer CJLM, Radaszkiewicz T, Ossekoppele GJ, van Krieken JHJM, Pals ST: Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 4:595-599, 1990
29. Hudson DL, Sleeman J, Watt FM: CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci 108:1959-1970, 1995
30. Ishii S, Ford R, Thomas P, Nachman A, Steele G Jr, Jessup JM: CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen. Surg Oncol 2:255-264, 1993
31. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673-685, 1995
32. Jalkanen ST, Jalkanen M: Lymphocyte CD44 binds to the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817-825, 1992
33. Jalkanen ST, Bargatze RF, Herron LR, Butcher EC: A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16:1195-1202, 1986
34. Jalkanen ST, Joensuu H, Soderstrom KO, Klemi P: Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invest 87:1835-1840, 1991
35. Joensuu H, Klemi PJ, Jalkanen S: Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br J Cancer 68:428-432, 1993
36. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW: Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182:419-429, 1995
37. Knox P, Wells P: Cell adhesion and proteoglycans: The effect of exogenous proteoglycans on the attachment of chick embryo fibroblasts to tissue culture plastic and collagen. J Cell Sci 40:77-88, 1979
38. Koopmann G, Heider K-H, Horst E, et al: Activated human lymphocytes and aggressive non Hodgkins' lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897-904, 1993
39. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54:271-335, 1993
40. Lesley J, English N, Perschl A, Gregoroff J, Hyman R: Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44show differences in glycosylation. J Exp Med 182:431-437, 1995
41. Mackay CR, Terpe H-J, Stauder R, Marston WL, Stark H, Günthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71-82, 1994
42. Miyake K, Underhill CB, Lesley J, Kincade PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172:69, 1990
43. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J: The chondroitin sulfate of invariant chain can enhance stimulation of T-cell responses through interaction with CD44. Cell 74:257-268, 1993
44. Orteu CH, Li W, Allen MH, Smith NP, Barker JNWN, Whittaker SJ: CD44 variant expression in cutaneous T-cell lymphoma. J Cutan Pathol 24:342-349, 1997
45. Pals ST, Horst E, Ossekoppele GJ, Figdor CG, Scheper FJ, Meijer CJLM: Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood 73:885-888, 1989
46. Picker LJ, Michie SA, Rott LS, Butcher EC: A unique phenotype of skin-associated lymphocytes in humans. Am J Pathol 136:1053-1068, 1990
47. Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC: ELAM-1 is an adhesion molecule for skin homing T cells. Nature 349:796-799, 1991
48. Pure E, Camp RL, Perrit D, Panettieri RA, Lazaar AL, Nayak S: Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J Exp Med 181:55-62, 1995
49. Reber S, Matzku S, Günthert U, Ponta H, Herrlich P, Zöller M: Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer 46:919-927, 1990
50. Rich AM, Pearlstein E, Weissman G, Hoffstein ST: Cartilage proteoglycans inhibit fibronectin-mediated adhesion. Nature (Lond) 293:224-226, 1981
51. Ristamäki R, Joensuu H, Söderström K-O, Jalkanen S: CD44v6 expression in Non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J Pathol 176:259-267, 1995
52. Rösel M, Seiter S, Zöller M: CD44v10 expression in the mouse and functional activity in delayed type hypersensitivity. J Cell Physiol 171:305-317, 1997
53. Rosenberg LC, Choi HU, Tang LH, et al: Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. J Biol Chem 260:6304-6313, 1985
54. Rudy W, Hoffmann M, Schwartz-Albiez R, Zöller M, Heider K-H, Ponta H, Herrlich P: Two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53:1262-1268, 1993
55. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467, 1977
56. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164, 1992
57. Seiter S, Arch R, Reber S, et al: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177:443-455, 1993
58. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314, 1994
59. Stamenkovic I, Amiot M, Pesando JM, Seed D: A lymphocyte molecule implicated in lymph node homimg is a member of the cartilage link protein family. Cell 56:1057-1062, 1989
60. Stamenkovic I, Aruffo A, Amiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate bearing cells. EMBO J 10:343-348, 1991
61. Stauder R, Eisterer W, Thaler J, Günthert U: CD44 variant isoforms in Non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 85:2885-2899, 1995
62. Sy MS, Guo Y-J, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174:859-866, 1991
63. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-Cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79-82, 1993
64. Terpe H-J, Stark H, Prehm P, Günthert U: CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignent human fetal and adult tissue. Histochemistry 101:79-89, 1994
65. Toyama-Sorimachi N, Sorimachi H, Tobita Y, Kitamura F, Yagita H, Suzuki K, Miyasaka M: A novel ligand for CD44 is serglycin, a hemapoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J Biol Chem 270:7437-7444, 1995
66. Uksila J, Salmi M, Butcher EC, Tarkkanen J, Jalkanen S: Function of lymphocyte homing-associated adhesion molecules on human natural killer and lymphokine-activated killer cells. J Immunol 158:1610-1617, 1997
67. Underhill C: CD44: the hyaluronan receptor. J Cell Sci 103:293-298, 1992
68. Wagner SN, Ruhri C, Kunth K, Holecek BU, Goos M, Höfler H, Atkinson MJ: Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma. Diagn Mol Pathol 1:200-205, 1992
69. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (eta-1). Science 271:509-512, 1996
70. Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the european organization for research and treatment of cancer. Blood 90:354-371, 1997
71. Yamagata M, Suzuki S, Akiyama SK, Yamada KM: Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J Biol Chem 264:8012-8018, 1989
72. Zöller M: CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. J Mol Med 73:425-438, 1995